⚡ Quick Start — If You Read Nothing Else
The 10 most important things to know about HIV and thinking & memory.
- HIV can affect thinking and memory — but severe “HIV dementia” is now rare. Thanks to effective HIV treatment, the severe form (HIV-associated dementia, HAD) has become uncommon. Milder cognitive changes still occur and are what most people experience today.
- Doctors describe a spectrum called HAND (HIV-associated neurocognitive disorder). It ranges from changes seen only on testing (ANI), to mild symptoms that affect daily life a little (MND), to the rare severe form (HAD).
- The single most important treatment is staying on effective HIV medication with the virus suppressed. Sustained viral suppression protects the brain and prevents most cognitive decline. This is the foundation of everything else.
- Never stop or change your HIV medicines on your own. Interruptions can let the virus rebound in the body and the brain. Always make changes with your HIV clinician.
- Many thinking problems in people with HIV are caused by something other than HIV — and many are treatable. Depression, poor sleep, alcohol or drug use, other infections, medication side effects, thyroid or vitamin problems, and aging-related conditions can all affect thinking and should be looked for first.
- As people with HIV live longer, ordinary aging conditions matter. Vascular disease (high blood pressure, diabetes, cholesterol) and Alzheimer's-type changes can add to or explain cognitive symptoms, so managing heart and metabolic health protects the brain.
- Sometimes the virus “escapes” into the spinal fluid even when blood tests look fine. This uncommon situation (CSF viral escape) can cause new neurologic symptoms and is treatable by adjusting HIV medicines — which is why new or worsening symptoms deserve evaluation.
- Get evaluated for sudden or rapid changes. A fast decline, new confusion, fever, severe headache, seizures, weakness, or vision changes is not typical of HAND and can signal a brain infection or other emergency — seek care promptly.
- There is no specific “HAND pill” yet. Beyond effective HIV treatment, care focuses on finding and treating other causes, cognitive rehabilitation, and supporting daily function and mood. Research continues.
- You are not alone, and stigma is not your fault. Cognitive symptoms can be frightening and isolating. Honest information, support, and good care make a real difference — and the outlook today is far better than in the early years of the epidemic.
Understanding HIV and Thinking & Memory
If you are living with HIV and have noticed changes in your thinking, memory, or concentration — or you are supporting someone who has — it is natural to feel worried. This guide explains, in plain and non-judgmental language, how HIV can affect the brain, why staying virally suppressed is so protective, what else can cause these symptoms, how the condition is diagnosed and managed, and where to find support. The overall message is honest but hopeful: the picture today is dramatically better than it was decades ago.
HIV-associated neurocognitive disorder (HAND) is the term for thinking and memory difficulties related to HIV's effects on the brain. In the era before effective treatment, a severe form — HIV-associated dementia (HAD) — was common and devastating. Today, with effective antiretroviral therapy (ART) and sustained suppression of the virus, severe HAD has become rare. What remains, and what most people experience, are milder forms.
Why the picture has changed so dramatically
In the 1980s and early 1990s, before effective combination treatment, HIV-associated dementia was common and often severe, developing in people with advanced disease and very low immune counts. The arrival of effective antiretroviral therapy transformed this almost completely: by suppressing the virus and restoring the immune system, treatment prevents most of the brain injury that drove severe dementia, and the rate of severe HAD fell sharply. What persists today is mostly milder impairment, plus the effects of aging and other conditions in a population now living into older age with HIV. Understanding this history matters because it is the source of genuine hope: the single most powerful brain-protecting intervention — effective, sustained treatment — is widely available and works. It also explains why the milder forms that remain are often intertwined with other causes that can themselves be treated.
The HAND spectrum: ANI, MND, and HAD
Doctors describe HAND as a spectrum of severity, defined by formal testing and how much daily life is affected:
- ANI (asymptomatic neurocognitive impairment): changes detectable on neuropsychological testing but not noticeably affecting everyday function. This is the most common category.
- MND (mild neurocognitive disorder): mild difficulties that do have some effect on daily activities — for example, in work, managing medications, or finances.
- HAD (HIV-associated dementia): the severe form, with marked impairment affecting independence. It is now rare in well-treated populations.
This classification (the “Frascati” criteria) is widely used, though experts are actively debating and refining how best to describe and report cognitive impairment in people with HIV — a 2023 international consensus has proposed updated terminology.
A condition that has changed — and keeps improving
If older information or stories from the early epidemic have shaped your fears, it is important to know how much has changed. The severe, rapidly progressive HIV dementia of the pre-treatment era is now uncommon, and people with HIV today routinely live long, full lives. The cognitive issues that remain are usually milder, often have treatable contributors, and can frequently be stabilized. Diagnosis is more precise, the importance of treating co-existing conditions is better understood, and tools to help people stay on treatment (including long-acting injections) keep improving. This is not to minimize real symptoms or the worry they cause — but to frame them accurately: with good HIV care and attention to the whole picture, the outlook is far more hopeful than it once was.
How HIV affects the brain
HIV can enter the brain early in infection. Even when the virus is well controlled in the blood, low-level inflammation and the long-term effects of prior, untreated infection (a “legacy” effect) can contribute to cognitive changes. The good news is that keeping the virus suppressed quiets much of this process. The symptoms people notice most are in attention and concentration, the speed of thinking, memory (especially recalling things), and complex tasks like planning — rather than the language and recognition problems more typical of Alzheimer's disease.
What the symptoms can look like
The cognitive changes of HAND tend to be “subcortical” in flavor — meaning they affect the speed and efficiency of thinking more than the kind of dense forgetfulness seen in Alzheimer's. People often describe mental slowing, trouble concentrating or multitasking, forgetfulness for recent events or appointments, difficulty finding words or following complex conversations, and sometimes slowed movements or reduced coordination. Apathy or low motivation, and changes in mood, are common and can overlap with depression. Crucially, these symptoms are often subtle and may fluctuate with sleep, stress, mood, and other health issues — which is exactly why a careful evaluation that looks beyond HIV is so important. A sudden or dramatic change, by contrast, is not typical of HAND and should prompt urgent assessment for another cause.
Who is affected, and the global picture
Milder cognitive changes are common among people living with HIV — studies estimate that a substantial proportion have some degree of measurable impairment, though much of it is mild and may not affect daily life. The burden is greater, and more severe forms more common, in settings where diagnosis comes later and treatment access or continuity is limited, including parts of sub-Saharan Africa. Worldwide, the most powerful tools remain early diagnosis of HIV, prompt and sustained treatment, and attention to the other conditions that affect the brain.
Common questions, honest answers
- “Does HIV cause dementia?” It can, but the severe form is now rare with effective treatment. Most cognitive change today is mild, and a lot of it comes from causes other than HIV that can be treated.
- “Will it keep getting worse?” Usually not, if your virus stays suppressed and other causes are addressed. Many people are stable for years, and some improve when a treatable cause (like depression) is found.
- “Will my HIV medicine fix my memory?” Effective treatment protects your brain and prevents most decline, but it does not act as a memory drug. There is no specific “HAND pill” beyond good HIV care.
- “My blood test says undetectable — so why am I having symptoms?” Several reasons are possible: another treatable cause (mood, sleep, medication, aging), prior damage from before treatment, or, uncommonly, the virus escaping into the spinal fluid. That is why a careful look is worthwhile.
- “Should I switch to a brain-penetrating regimen?” Probably not on that basis alone — the idea sounds logical but is not proven to help cognition, and switching an effective regimen has its own risks. Discuss it with your HIV clinician.
- “Is this my fault?” No. Stigma and self-blame are common and unhelpful. The focus now is on protecting your health and getting support.
Questions to ask your doctor
- Are my thinking changes related to HIV, or could something else be causing them?
- Is my virus fully suppressed, and is my current HIV regimen the best one for me?
- Could depression, sleep, substance use, other medicines, or another condition be contributing?
- Do I need neuropsychological testing to understand what is going on?
- What symptoms should make me seek urgent care?
Diagnosis & Causes
Diagnosing HAND is as much about ruling out other causes as it is about HIV itself. Because so many things can affect thinking, a careful evaluation protects you from missing a treatable problem.
How it is diagnosed
There is no single blood test for HAND. The diagnosis is made by an experienced clinician who combines your history, an examination, cognitive testing, and tests to exclude other causes. Key parts include:
- Neuropsychological testing — structured tests across several thinking domains (attention, memory, processing speed, executive function, motor speed). This maps your strengths and weaknesses and establishes a baseline to track over time.
- A review of your HIV status — current and past viral load and CD4 count, your treatment history, and whether the virus is suppressed.
- A thorough search for other causes (below).
- Brain imaging (MRI) and, in some cases, a spinal fluid (lumbar puncture) test — especially if symptoms are new, rapid, or unusual.
Why ruling things out matters so much
It is worth understanding why doctors spend so much effort looking for other causes. In the modern treatment era, when someone with well-controlled HIV has cognitive symptoms, the cause is frequently not active HIV in the brain but something else — and that something else is often very treatable. Treating depression, improving sleep, addressing alcohol or drug use, adjusting a medication that clouds thinking, correcting a thyroid or vitamin problem, or managing blood pressure and diabetes can each produce real improvement. Missing one of these and assuming “it's just the HIV” would mean missing a chance to help. It also matters because some causes — like an opportunistic brain infection in someone with a low CD4 count — are urgent. So a thorough evaluation is not bureaucratic caution; it is how the most fixable problems get fixed.
Neuropsychological testing, explained
Neuropsychological testing is simply a structured, standardized way of measuring different thinking abilities — attention, processing speed, memory, problem-solving, language, and fine-motor speed. A neuropsychologist administers a battery of tasks (usually over a couple of hours) and compares your results to what is expected for your age and background. This does several things: it confirms whether there really is impairment (and in which areas), it helps tell HIV-related patterns apart from depression, Alzheimer's, or medication effects, and it gives a baseline so future testing can show whether things are stable, improving, or declining. Brief in-office screens exist and are useful for flagging concerns, but they are not detailed enough on their own to diagnose the milder categories. Going in well-rested, with your glasses and hearing aids, and having treated any acute issues, gives the most accurate picture.
Other causes that must be considered
- Depression and anxiety — very common and can closely mimic cognitive impairment; highly treatable.
- Alcohol and other substance use — can impair thinking directly and interact with medicines.
- Other infections of the brain — especially important if CD4 counts are or were low (for example, toxoplasmosis, cryptococcal meningitis, PML, or CMV).
- Medication effects — some medicines (including, historically, the HIV drug efavirenz, and many sedatives and anticholinergic drugs) can cloud thinking.
- Sleep disorders, thyroid problems, vitamin deficiencies (such as B12), and metabolic issues.
- Aging-related conditions — vascular (small-vessel) disease and Alzheimer's-type changes become more relevant as people with HIV live longer.
Brain imaging and the spinal-fluid test
Not everyone needs a brain scan or a spinal tap, but they are important in certain situations. A brain MRI creates detailed pictures of the brain and is used mainly to rule out other problems — an opportunistic infection, lymphoma, a stroke, or significant small-vessel disease — and to see the overall state of the brain. A lumbar puncture (spinal tap), in which a small sample of the fluid around the spinal cord is taken with local anesthetic, is used when symptoms are new, rapid, or unusual: it can detect infections and, importantly, check whether the virus is active in the spinal fluid (CSF viral escape). These tests are most useful when the picture is unclear or concerning; for stable, mild, long-standing symptoms in someone well-controlled, they are often not necessary. Your team will explain why a particular test is recommended in your case.
CSF viral escape
In an uncommon but important situation called cerebrospinal fluid (CSF) viral escape, the virus continues to replicate in the brain and spinal fluid even though blood tests show it is suppressed. This can cause new neurologic or cognitive symptoms and is detected by testing the spinal fluid. It is treatable — usually by adjusting the HIV regimen based on resistance testing — which is one reason new or worsening neurologic symptoms in someone who seems well-controlled should be evaluated rather than dismissed.
What makes this worth knowing is the apparent paradox: your routine blood tests can look perfect — “undetectable” — while the virus is quietly active in the protected space around the brain. That is why doctors will sometimes recommend a spinal-fluid test even when blood results are reassuring, if you develop new neurologic or thinking symptoms. The encouraging part is that, when it is found, it can usually be managed by changing the HIV medicines to ones that work better against the specific virus in the spinal fluid. CSF escape is not common, so this is not a reason for alarm at every off day — but it is a reason to take genuinely new or worsening symptoms seriously and get them checked rather than assuming an undetectable blood test rules everything out.
Questions to ask your doctor
- What testing will you do, and what causes are you trying to rule out?
- Could my symptoms be from depression, sleep, substance use, or a medication?
- Do I need an MRI or a spinal fluid test, and why?
- Is there any concern about CSF viral escape in my case?
Treatment & Protecting the Brain
There is no specific drug that treats HAND itself, but there is a great deal you and your team can do to protect your brain and improve how you function.
Effective antiretroviral therapy — the foundation
Staying on an effective HIV regimen with the virus suppressed is the single most important thing for your brain. Sustained suppression prevents most cognitive decline, and starting treatment early protects the brain from the start. If you have trouble with adherence, tell your team — there are now options including simpler regimens and even long-acting injectable treatments (given every couple of months) that can make staying suppressed easier. Whether these newer options have specific brain benefits is not yet known, but anything that helps you stay reliably suppressed protects your brain.
Why adherence is brain protection
It is worth connecting two ideas that are really one: staying on your HIV medicine consistently is, for your brain, a form of treatment in itself. Every period of suppression keeps inflammation and viral activity in the brain low; gaps allow the virus to rebound, including in the nervous system. This is also why cognitive symptoms create a tricky loop — thinking and memory problems can make it harder to take pills reliably, which then threatens suppression. Breaking that loop is a priority: reminder apps and alarms, pill organizers or blister packs, linking doses to daily routines, pharmacy auto-refill and delivery, and — increasingly — long-acting injectable treatment given every couple of months so there are no daily pills to remember. If anything is getting in the way of taking your medicine (cost, side effects, mental health, housing, simply forgetting), tell your team; these are solvable problems, and solving them protects your brain.
Understanding the foundation a bit more
“Effective antiretroviral therapy with sustained suppression” is a phrase worth unpacking, because it is the heart of brain protection. Modern HIV regimens are highly effective and, for most people, well tolerated — often a single daily tablet, and now sometimes an injection every couple of months. “Suppression” means the amount of virus in your blood is so low it is undetectable; at that level the virus is not damaging your immune system and the inflammation that can harm the brain is greatly reduced. “Sustained” is the key word: it is the consistency over months and years that protects you, which is why missed doses and treatment gaps are the main threat. Starting treatment early, before the immune system and brain take damage, gives the best long-term protection, but starting at any point helps. If you have been off treatment or had interruptions in the past, getting back to steady suppression now is still very worthwhile for your brain.
A note on “CNS-penetrating” regimens
You may read that certain HIV drugs penetrate the brain better than others (described by a “CNS penetration effectiveness,” or CPE, score). It is an appealing idea, but the evidence that choosing a higher-penetration regimen actually improves cognition is debated and unproven. Doctors do not routinely switch effective regimens just to raise a CPE score, though they may reconsider the regimen in specific situations such as CSF viral escape. Don't let claims about CPE drive treatment decisions on their own.
Treating other causes
Because so much cognitive trouble in HIV comes from other, treatable conditions, this is where real gains are often made:
- Treat depression and anxiety — often dramatically improves thinking, energy, and motivation.
- Address alcohol and substance use with support and treatment.
- Improve sleep and treat sleep disorders.
- Review medications to reduce those that cloud thinking.
- Correct thyroid, vitamin (e.g., B12), and metabolic problems.
The biggest gains often come from treating other conditions
It bears repeating because it is so often where improvement comes from: in someone whose HIV is well controlled, the most effective “cognitive treatment” is frequently treating a co-existing condition. A few examples make this concrete. Treating depression can restore concentration, memory, and motivation that looked like dementia. Diagnosing and treating sleep apnea can sharpen daytime thinking dramatically. Cutting back alcohol or stopping a sedating or anticholinergic medication can lift mental fog within weeks. Correcting a low B12 or an underactive thyroid can reverse symptoms entirely. Getting blood pressure and blood sugar under control protects the brain over the longer term. None of these is a HAND-specific drug, yet together they are usually the most powerful tools available — which is why a thorough evaluation and a willingness to address the “whole person” matter so much.
Protecting the brain as you age
As people with HIV live longer, ordinary brain-health measures matter more than ever. Controlling blood pressure, diabetes, and cholesterol, not smoking, staying physically active, eating well, staying socially and mentally engaged, and limiting alcohol all protect cognition. These steps reduce the vascular disease that can add to or explain cognitive symptoms, and they are good for overall health and longevity with HIV.
Brain-health habits, concretely
The lifestyle steps that protect the brain are the same ones that support healthy aging with HIV, and they are worth being specific about. Aim for regular physical activity — even brisk walking most days improves mood, sleep, and cognition. Eat a heart-healthy, vegetable-rich diet and keep alcohol modest. Don't smoke; quitting is one of the highest-impact things you can do for both heart and brain, and help is available. Have your blood pressure, blood sugar, and cholesterol checked and treated to target. Prioritize sleep and get sleep problems (like snoring with daytime sleepiness, which can be sleep apnea) evaluated. Stay socially connected and mentally engaged — hobbies, learning, and relationships all help. And keep up with your overall preventive care. None of these is a flashy “treatment,” but together, alongside sustained viral suppression, they are genuinely protective and within your control.
Cognitive rehabilitation
Cognitive rehabilitation — structured training and strategies to strengthen attention, memory, and daily functioning — shows promise for improving everyday cognition in HAND, and newer technology-based and game-based approaches are being studied. Practical strategies (calendars, reminders, routines, breaking tasks into steps, reducing distractions) help in daily life. Occupational therapy can tailor these to your needs.
Questions to ask your doctor
- Is my HIV treatment working as well as it can, and is adherence an issue we should address?
- Would a long-acting or simpler regimen help me stay suppressed?
- Have we treated my mood, sleep, and any substance use?
- What can I do to protect my brain as I age with HIV?
- Is cognitive rehabilitation available to me?
Living with HAND & Clinical Trials
Most people with milder HAND can live full, independent lives, especially with the virus suppressed and other causes managed. Here is what to expect and how research is progressing.
Warning signs that need prompt care
While most HAND is mild and slowly changing, certain symptoms are not typical of it and deserve urgent evaluation, because they may point to a different, sometimes treatable or dangerous, problem: a rapid worsening of thinking over days to weeks; new confusion or disorientation; fever with headache or a stiff neck; a severe or unusual headache; seizures; new weakness, numbness, trouble speaking, or vision changes; or new psychiatric symptoms like hallucinations. These can signal a brain infection, CSF viral escape, a stroke, or another emergency — especially if your CD4 count is or has been low. Do not wait to “see if it passes”; contact your team or seek emergency care. Keeping a record of your usual baseline helps you and your clinicians recognize when something has genuinely changed.
What to expect over time
For most people on effective treatment, milder cognitive changes tend to be stable rather than relentlessly progressive, and some improve when treatable causes are addressed. Severe progression to dementia is now uncommon in well-treated populations. That said, some deficits, especially those from prior untreated infection, may persist, and this guide is honest about that. Aging, vascular disease, and other conditions can also affect the long-term picture. Regular follow-up, sustained suppression, and attention to overall health give the best outcomes.
It helps to set realistic, hopeful expectations. The goal of care is not usually a dramatic “cure” of cognitive symptoms but rather stability, prevention of decline, and improvement in the areas that have a treatable cause — together with strategies that help you function well day to day. Many people, once their virus is suppressed, their mood and sleep are addressed, and their other health conditions are managed, find that their thinking is better than they feared and stays steady for years. Periodic re-testing lets you and your team see the trend objectively rather than worrying about every off day, which is reassuring. And if something does change — especially suddenly — that is the signal to look for a new, often treatable cause rather than to assume the worst.
Aging with HIV and your brain
One of the biggest shifts in HIV care is that people now live long, full lives — which means ordinary aging and its effects on the brain matter more than the virus for many people. Conditions like high blood pressure, diabetes, high cholesterol, and the small-vessel disease they cause can quietly affect thinking, and Alzheimer's-type changes can occur too, sometimes alongside HIV's effects. The encouraging flip side is that these are exactly the things you can act on. Controlling blood pressure and blood sugar, managing cholesterol, not smoking, staying physically active, eating well, limiting alcohol, sleeping enough, and staying socially and mentally engaged all protect the brain — and they extend healthy life with HIV in general. If aging-related cognitive disease is suspected, it deserves its own proper evaluation, because some of those conditions have their own specific treatments. Thinking of brain health as part of healthy aging with HIV, rather than only an HIV problem, opens up more ways to help.
Daily strategies that help
- Use external aids: calendars, alarms, pill organizers or reminders, and notes.
- Keep predictable routines and reduce distractions for important tasks.
- Break complex tasks into smaller steps; do demanding tasks when you are freshest.
- Protect sleep, stay active, and stay socially and mentally engaged.
- Use adherence supports (apps, blister packs, or long-acting options) to keep the virus suppressed.
Small environmental and routine changes add up. Keep important items (keys, wallet, phone, medications) in the same place every time. Use a single calendar — paper or digital — for all appointments and set reminders the day before and the hour before. When you need to remember something, write it down immediately rather than trusting you will recall it later. Tackle complex or important tasks when you are most alert, and break them into smaller steps. Reduce distractions (turn off background TV or noise) when concentrating. Get enough sleep, stay physically active, limit alcohol, and keep socially and mentally engaged — all of which support thinking. And be patient and kind with yourself: frustration and self-criticism make concentration worse, while a calm, structured approach makes the most of the abilities you have.
Making cognitive rehabilitation part of daily life
Cognitive rehabilitation works best when its strategies become habits rather than one-time exercises. The core ideas are to compensate (use external aids so your brain has to hold less) and to train (practice attention and memory skills). In practice that means leaning on calendars, alarms, and note-taking; keeping items in consistent places; doing one thing at a time and reducing background distraction; tackling demanding tasks at your sharpest time of day; and using checklists for multi-step jobs. Occupational therapists can tailor these to your routine and home. Newer approaches, including computer- and game-based training, are being studied and look promising for attention in particular. None of this replaces effective HIV treatment, but combined with it, these strategies can meaningfully improve day-to-day functioning and confidence.
>Clinical trials and the research pipeline
There is no proven medicine that specifically treats HAND beyond effective HIV therapy, and several adjunctive ideas have been tested with limited success — an honest picture. Examples studied include:
- Maraviroc (a CCR5-blocking HIV drug) added to treatment — small studies and trials (such as NCT02159027 and the InMIND trial, NCT02519777) explored whether intensifying therapy helps cognition, with limited and mixed results.
- Intranasal insulin — tested for HAND (NCT03081117) on the basis of promising laboratory work; the trial was cut short by the COVID-19 pandemic.
- Other agents — paroxetine showed a preliminary signal in one small trial, while several anti-inflammatory and neuroprotective approaches have not panned out.
- Cognitive rehabilitation and brain-stimulation approaches continue to be studied.
A realistic view of research
It is worth being clear-eyed and hopeful at once. The biggest “treatment advance” for HIV and the brain has already happened — it is effective antiretroviral therapy, which prevents most of the severe disease that was once common. Beyond that, the search for an add-on drug that specifically reverses HAND has so far been disappointing, with several promising ideas not panning out in trials; this guide does not overstate the pipeline. Where research is genuinely moving is in better understanding mixed causes (HIV plus aging and vascular disease), better biomarkers to tell active injury from old, stable damage, strategies to reduce lingering brain inflammation, tools to make staying suppressed easier (like long-acting treatment), and non-drug approaches like cognitive rehabilitation. If you are interested in contributing to and possibly benefiting from this work, ask your clinician about trials and look at ClinicalTrials.gov — and meanwhile, the proven steps (suppression, treating other causes, brain-healthy living) remain your strongest tools.
Questions to ask your doctor
- Is my cognition stable, and what would prompt a change in the plan?
- What everyday strategies would help me most?
- Are there clinical trials I might be eligible for?
Support & Practical Help
Living well with HIV and cognitive change is easier with the right support, resources, and a few practical strategies. Stigma can make this harder — you deserve compassionate, judgment-free care.
Care for the whole person
Living well with HIV and cognitive change is rarely about a single pill or appointment; it is about caring for the whole person. That means treating the virus effectively and consistently, yes — but also tending to mental health, sleep, substance use, heart and metabolic health, social connection, and the practical supports (housing, transportation, finances, insurance) that make staying in care possible. It means using the strategies and tools that help you function day to day, and leaning on the people and organizations that can help. And it means being treated with dignity and without stigma. When all of these are addressed together, most people find their thinking is steadier and their lives fuller than they feared. This guide's central, honest message is exactly that: the modern era has transformed this condition, and a thoughtful, whole-person approach gives you real reasons for hope.
Staying on treatment and on track
Because viral suppression is the foundation, supports that help you stay on treatment directly protect your brain. Ask about adherence tools (reminder apps, blister packs, pharmacy syncing), and about simpler or long-acting injectable regimens if daily pills are hard. If cost or access is a barrier, programs exist to help (see below). Cognitive symptoms can themselves make adherence harder, so building in reminders and support is part of good care.
If remembering daily medication has become difficult, that is exactly the kind of thing to raise with your team rather than struggle with alone — missed doses are the main threat to the suppression that protects your brain. Concrete options include pairing your dose with a fixed daily habit, weekly blister packs or filled organizers, phone or smart-speaker reminders, automatic pharmacy refills and delivery, and — increasingly — long-acting injections given every one to two months so there are no daily pills at all. A case manager can also help remove the practical barriers (cost, transportation, insurance) that get in the way. The goal is simple: make staying suppressed as easy and reliable as possible, because that is the single most powerful thing you can do for both your overall health and your brain.
Working well with your care team
Cognitive symptoms can make medical visits harder — remembering questions, taking in information, recalling instructions afterward. A few habits help a great deal: write down your questions and concerns before the visit and bring the list; bring a trusted family member or friend to be a second set of ears; ask the team to write key points down or to summarize the plan; keep an up-to-date list of all your medicines (HIV and otherwise) and any supplements; and don't hesitate to say “can you explain that again” or “can I have that in writing.” If appointments feel rushed, it is reasonable to ask for a longer visit or a follow-up call. Good HIV care is a partnership, and a team that knows you are having thinking difficulties can adapt to support you — for example, by simplifying your regimen, setting up reminders, or connecting you with a case manager.
Emotional health and stigma
Anxiety, depression, and the weight of stigma are common and treatable, and they directly affect thinking and quality of life. Counseling, peer support, and connecting with others living with HIV help. Many HIV clinics integrate mental-health and social services; ask for a referral, and know that seeking support is a strength.
It is worth saying plainly: depression in particular can look exactly like a memory or concentration problem — slowed thinking, forgetfulness, loss of motivation — and treating it can lift the “fog” substantially. So mental-health care is not separate from brain health; it is central to it. Stigma adds a heavy layer, sometimes leading people to hide symptoms or avoid care. You deserve compassionate, confidential, judgment-free support, and you are far from alone — millions of people live well with HIV. Peer-support programs, where you connect with others who have walked the same path, are especially powerful for both mood and practical coping. If you ever feel hopeless or have thoughts of harming yourself, reach out immediately — in the US you can call or text 988 for the Suicide and Crisis Lifeline.
Pregnancy and family planning
HIV affects people of reproductive age, so pregnancy is relevant. The key messages: effective HIV treatment during pregnancy protects the parent's health (including the brain) and dramatically reduces the chance of passing HIV to the baby. Do not stop HIV medication if you become or plan to become pregnant — instead, work with your HIV and obstetric team to choose a regimen that is effective and safe in pregnancy. If you are planning a family, discuss it with your team; with modern care, people with HIV can have healthy pregnancies and HIV-negative children.
Mountain West / Utah
- University of Utah Health — Clinical HIV Program (Infectious Diseases) and Neurology (Salt Lake City): HIV care, neurocognitive evaluation, and referral; University of Utah Health 801-585-7575.
- Utah AIDS / Ryan White HIV programs — case management, medication-assistance, and support services across Utah.
- Intermountain Health infectious diseases and neurology services; George E. Wahlen VA Medical Center for eligible veterans.
- Utah Department of Health and Human Services HIV services — testing, linkage to care, and prevention resources.
Practical help with the essentials
Cognitive symptoms make the logistics of life harder, so practical support is part of care. Case managers — often available through HIV clinics and Ryan White-funded programs — can help with medication-assistance programs (so cost is not a barrier to staying suppressed), insurance and benefits, transportation to appointments, housing, and food security, all of which affect both health and thinking. If managing medications is getting difficult, ask specifically about tools (pillboxes, blister packs, reminder apps, pharmacy delivery and synchronization) and about long-acting injectable treatment. Bring a trusted family member or friend to appointments if helpful, keep an up-to-date list of all your medicines, and don't hesitate to ask the team to write things down. These supports exist precisely so that thinking difficulties do not derail the treatment that protects your brain.
National resources
- CDC HIV information (cdc.gov/hiv; CDC-INFO 1-800-232-4636) — trustworthy information and referrals.
- HIV.gov and the Ryan White HIV/AIDS Program (hrsa.gov) — care, services, and locating a provider.
- The Well Project and POZ — community, education, and support for people living with HIV.
- NIH ClinicalTrials.gov and the AIDS Clinical Trials Group (ACTG) — research and trials.
International access
HIV care — and therefore brain protection — varies worldwide. In high-resource settings with reliable treatment and suppression, severe HIV dementia is rare and milder forms predominate. In many lower-resource settings, later diagnosis, treatment interruptions, and limited access mean a higher burden of HAND and more advanced presentations; expanding early diagnosis and sustained treatment is the central global priority. The Frascati classification is used internationally, with ongoing efforts (a 2023 international consensus) to refine the terminology, and major guidelines (such as those from the European AIDS Clinical Society) address neurocognitive care.
If you live outside the United States, the core principles are the same everywhere: get and stay on effective HIV treatment, keep the virus suppressed, look for and treat other causes of cognitive symptoms, and manage overall health as you age. What differs is access — to medications, to newer long-acting options, to neuropsychological testing, and to specialized neurologic care. In settings where these are limited, the highest-impact steps are still the most basic: timely HIV diagnosis, reliable access to treatment, and support for staying on it. Ask your local HIV service what is available where you live, and whether research studies offer additional options. Wherever you are, the transformation that effective treatment has brought to this condition applies — the earlier and more consistently HIV is treated, the more the brain is protected.
What has not worked
Being clear about what does not help prevents false hope and unnecessary treatment. Beyond effective HIV therapy, no adjunctive drug has been proven to treat HAND. Agents tested without convincing benefit include minocycline, selegiline, memantine, lithium, and valproate, among others. Choosing HIV regimens purely to maximize a CPE (CNS-penetration) score has not been shown to improve cognition and is not recommended on its own. And no supplement or alternative product treats HIV or HAND — some can even interfere with HIV medicines, so always tell your team what you take.
Key sources
Based on the Frascati consensus criteria (Antinori 2007) for HAND classification; the CHARTER cohort and international epidemiologic studies; 2023 international consensus recommendations on cognitive impairment in HIV; European AIDS Clinical Society and AAN guidance; research on CSF viral escape; and adjunctive-therapy trials including maraviroc (NCT02159027), the InMIND trial (NCT02519777), and intranasal insulin (NCT03081117), plus ClinicalTrials.gov registry data. This guide is educational and is not a substitute for advice from your own HIV and medical team.